Big Data
Big Data: is a field that treats ways to analyze, systematically extract information from, or otherwise deal with data sets that are too large or complex to be dealt with by traditional data-processing application software.
What's Popular in Big Data
C.E. CREDITS
Often overlooked but critical to most cannabis laboratory operations is sample workflow and sample preparation, having these areas figured out early in the start-up process is essential &nda...
C.E. CREDITS
The explosion of biomedical data such as in genomics, structure biology and pharmacology can provide new opportunities to improve our understanding of human physiology and disease. Understan...
NOV 04, 2020
8:00 AM PST
C.E. CREDITS
NOV 04, 2020
8:00 AM PST
Date: November 4, 2020 Time: 8:00am (PDT), 11:00am (EDT) High-content screening (HCS) is widely used for research in quantitative cellular biology and has proven to be a valuable tool in dru...
SEP 23, 2020
6:30 AM PDT
SEP 23, 2020
6:30 AM PDT
Single-cell mass cytometry identifies mechanisms of resistance to immunotherapy in AML 6:30–7:00 am PDT Presented By: Shelley Herbrich, PhD Understanding CD19 negative relapse followin...
NOV 04, 2020
8:00 AM PST
C.E. CREDITS
NOV 04, 2020
8:00 AM PST
Date: November 4, 2020 Time: 8:00am (PDT), 11:00am (EDT) High-content screening (HCS) is widely used for research in quantitative cellular biology and has proven to be a valuable tool in dru...
SEP 23, 2020
6:30 AM PDT
SEP 23, 2020
6:30 AM PDT
Single-cell mass cytometry identifies mechanisms of resistance to immunotherapy in AML 6:30–7:00 am PDT Presented By: Shelley Herbrich, PhD Understanding CD19 negative relapse followin...
AUG 07, 2020
12:00 PM PDT
AUG 07, 2020
12:00 PM PDT
This talk will touch on several key points: PhD (MD) important grounding in science; how to develop friendships, gather mentors and collaborators; keep up with the literature; look at eviden...
MAY 20, 2020
11:15 AM EDT | APAC MAY 21, 2020 2:15 PM CST
MAY 20, 2020
11:15 AM EDT | APAC MAY 21, 2020 2:15 PM CST
Background: CDK4/6 inhibitors increase tumor immunogenicity in preclinical models of breast cancer and several trials combining CDK4/6 inhibitors and anti-PD1/PDL1 therapies are underway. Ho...
